Safety of IL-17A Inhibitors in Patients With Moderate to Severe Psoriasis in a US Claims Data-Based Cohort Study
{{output}}
Background: Safety outcomes from IL-17A inhibitors have not been fully evaluated. Objective: Compare the risk of seven safety outcomes in patie... ...
